Cells containing Epstein-Barr nuclear antigen (EBNA) in peripheral blood

L. Gergely, J. Czegledy, L. Vaczi, A. Szalka, E. Berényi

Research output: Article

4 Citations (Scopus)


The anti-complement immunofluorescence method was used to demonstrate EBNA in B lymphocytes separated from the peripheral blood of patients with infectious mononucleosis (IM) or other diseases. In the acute phase of IM of Epstein-Barr virus (EBV) origin, 0.5-1% of the B lymphocytes proved to be positive in 6 of the 8 patients tested. In 2 of the positive cases the test was repeated 20 and 26 days, respectively, after clinical symptoms had appeared; the result was negative in both cases. No EBNA-positive cells were found in the peripheral blood of 17 patients with Hodgkin's disease, 3 with systemic lupus erythematosus and 2 with lymphosarcoma. It is supposed that EBNA-positive cells appear in detectable amounts exclusively in the acute phase of EBV infection.

Original languageEnglish
Pages (from-to)41-45
Number of pages5
JournalActa microbiologica Academiae Scientiarum Hungaricae
Issue number1
Publication statusPublished - nov. 2 1979


ASJC Scopus subject areas

  • Medicine(all)

Cite this